These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9231355)

  • 1. Influence of certain calcium-channel blockers on some aspects of lorazepam-dependence in mice.
    Saad SF; Khayyal MT; Attia AS; Saad ES
    J Pharm Pharmacol; 1997 Mar; 49(3):322-8. PubMed ID: 9231355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of flunarizine and diltiazem on physical dependence on barbital in rats.
    Suzuki T; Mizoguchi H; Noguchi H; Yoshii T; Misawa M
    Pharmacol Biochem Behav; 1993 Jul; 45(3):703-12. PubMed ID: 8392734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats.
    Gupta MB; Nath C; Patnaik GK; Saxena RC
    Indian J Med Res; 1996 Jun; 103():310-4. PubMed ID: 8707372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of renal dopamine D1 receptors in natriuresis induced by calcium channel blockers.
    Eisner GM; Yamaguchi I; Felder RA; Asico LD; Jose PA
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F965-70. PubMed ID: 7810704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ca2+ channel blockers on physical dependence on diazepam in mice.
    Mizoguchi H; Yoshiike M; Suzuki T; Misawa M
    Life Sci; 1993; 53(22):PL365-70. PubMed ID: 8231644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of [3H]dopamine uptake by flunarizine.
    Devoto P; Pani L; Kuzmin A; De Montis G
    Eur J Pharmacol; 1991 Oct; 203(1):67-9. PubMed ID: 1797556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented behavioral response and enhanced synaptosomal calcium transport induced by repeated cocaine administration are decreased by calcium channel blockers.
    Mills K; Ansah TA; Ali SF; Mukherjee S; Shockley DC
    Life Sci; 2007 Jul; 81(7):600-8. PubMed ID: 17689567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium antagonists on biogenic amines in discrete brain areas.
    Gaggi R; Gianni AM
    Eur J Pharmacol; 1990 Jun; 181(3):187-97. PubMed ID: 2384131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats.
    Nath C; Saxena RC; Gupta MB
    Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):167-71. PubMed ID: 10744342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalepsy induced by calcium channel blockers in mice.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1998 Mar; 19(2):115-22. PubMed ID: 9533112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel antagonist isradipine attenuates cocaine-induced motor activity in rats: correlation with brain monoamine levels.
    Mills K; Arsah TA; Ali SF; Shockley DC
    Ann N Y Acad Sci; 1998 May; 844():201-7. PubMed ID: 9668678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.
    Watson WP; Misra A; Cross AJ; Green AR; Little HJ
    Br J Pharmacol; 1994 Aug; 112(4):1017-24. PubMed ID: 7524989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists.
    Watson WP; Little HJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):329-36. PubMed ID: 7838926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral dopamine and noradrenaline in mice withdrawn from repeated morphine treatment and development of tolerance to a test dose of morphine.
    Etemadzadeh E
    Gen Pharmacol; 1994 Jul; 25(4):623-9. PubMed ID: 7958720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats.
    Baeyens JM; Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 May; 137(1):9-13. PubMed ID: 3609136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896.
    Lamb RJ; Griffiths RR
    Drug Alcohol Depend; 1984 Sep; 14(1):11-7. PubMed ID: 6435982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption.
    Bailey CP; Molleman A; Little HJ
    Br J Pharmacol; 1998 Jan; 123(2):215-22. PubMed ID: 9489608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.